Our NDA drug developed by ourself-Teng Nuo Er (TNR) project enter phase Ⅱ clinical trial at China in 2008.

TNR project inlcudes TNR powder and gel,its active ingredients is mica; its indications is for the treatment of chronic superficial gastritis (CSG) and chronic atrophic gastritis (CAG) and chronic enteritis. The chronic gastritis are clarified into CSG and CAG according to the degree of gastristis. There was reports is that incidence rate (IN)of chronic gastritis in China nearly reach 60%, and the IN of CAG is 20% in the IN of Chronic gastritis.So the market capacity is large for drug using for the treatment of chronic gastritis, and there are not chemical product in the treatment of CAG.